{
    "2019-11-29": [
        [
            {
                "time": "",
                "original_text": "淡马锡神操作？控股药企五日暴涨1100%",
                "features": {
                    "keywords": [
                        "淡马锡",
                        "控股药企",
                        "暴涨",
                        "1100%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：控股子公司独家产品首次被纳入《医保目录》",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股子公司",
                        "独家产品",
                        "医保目录"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)下属控股子公司脑血栓药物注射用尤瑞克林新纳入国家医保目录",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股子公司",
                        "脑血栓药物",
                        "尤瑞克林",
                        "医保目录"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)：上药天普独家产品注射用尤瑞克林新纳入国家医保目录",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上药天普",
                        "独家产品",
                        "尤瑞克林",
                        "医保目录"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)：上药天普获《药品GMP证书》",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上药天普",
                        "药品GMP证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：子公司产品新纳入国家医保目录",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "产品",
                        "医保目录"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}